Missiles or Medicine? The $200 Billion Choice That Will Change American Healthcare
The Pentagon has asked Congress for a $200 billion supplemental defense budget, a sum that eclipses the entire annual budget of the Department of Health and Human Services. At the same time, the administration proposes an $18 billion cut to the National Institutes of Health and a $3.6 billion reduction to the CDC, while trimming Medicare and ACA programs. The author argues that the opportunity cost of this request could fully fund the NIH for four years, eliminate the VA’s $170 billion infrastructure backlog, and clear veteran claims. The piece frames the spending clash as a choice between lethal capability and public health longevity.
Don't Get Billed: Avoiding Surprise Medical Costs & Medical Debt #CareTalk
The latest CareTalk episode spotlights the growing crisis of surprise medical bills that trap millions of Americans in debt. Patricia Kelmar of PIRG breaks down patient rights under the No Surprises Act and explains how the law reshapes billing practices....
Humana, Caught up in the Metastasizing Medicare Overbilling Scandal, Enters Our Imploded Stocks
Humana’s Medicare Advantage business, once a profit engine, is now under intense federal scrutiny for alleged overbilling and kickback schemes. The crackdown has stalled revenue growth and led to a February loss, pushing the stock 71% lower from its November 2022...
The Hidden Costs of Diffuse Accountability in Medical Teams
The article warns that expanding clinical authority without matching accountability creates diffuse responsibility that harms patient clarity and safety. It argues that diagnostic uncertainty cannot be captured by metric‑driven systems, leaving physicians to shoulder unmeasurable judgment. The piece calls for...
Would You Believe that 36% of Your Single Level Endoscopy Spine Patients Never Take an Opioid Post-Op?
A prospective cohort of 217 opioid‑naive patients undergoing outpatient cervical or lumbar spine surgery revealed dramatic variation in postoperative opioid consumption based on procedure complexity and technique. Single‑level cases averaged 75 MME, while multilevel procedures more than doubled that figure to...
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing
Eli Lilly is pressuring the U.K. government to raise NHS drug prices and eliminate the VPAG rebate scheme before it resumes new investment in Britain. The company is also exploring outcome‑based pricing for its anti‑obesity medicines. In parallel, Lilly struck a...
Is Online Trauma Therapy Effective? What the Research Shows
Recent research confirms that online trauma therapy delivers significant reductions in PTSD, anxiety, and related symptoms, performing on par with traditional in‑person care. Evidence‑based modalities such as TF‑CBT, EMDR, and somatic approaches translate effectively to secure video platforms. The studies...
Avutometinib and Defactinib
The FDA granted accelerated approval to the oral co‑pack Avutometinib and Defactinib for adults with KRAS‑mutated, recurrent low‑grade serous ovarian cancer (LGSOC) after prior therapy. The regimen pairs a RAF/MEK inhibitor with a FAK inhibitor, marking a rare “novel‑novel” combination...
Canopy Growth’s Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
Canopy Growth’s Apollo Cannabis Clinics was voted Best Medical Cannabis Clinic in the 2025 Toronto Star Readers’ Choice Awards, reflecting strong patient trust. The accolade spotlights Apollo’s free, fully virtual consultations that serve Canadians with personalized, evidence‑based treatment for chronic...
Sol-Millennium Medical Inc. Launches U.S. B2B eShop, Providing Direct Access to Safety Engineered Medical Devices Nationwide
Sol‑Millennium Medical Inc. has launched a dedicated U.S. B2B e‑commerce platform, b2b.solm.com, allowing healthcare providers nationwide to purchase its safety‑engineered medical devices directly. The site streamlines registration, pricing visibility, and order placement for settings ranging from physician offices to veterinary...
Eli Lilly Seeks Agreement with U.K. Government to Raise Prices for Medicines: Report
Eli Lilly is negotiating with the U.K. government to raise NHS drug prices and overhaul the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG). The company argues that current rebate rates of 25‑33% of revenues are unsustainable and threaten...
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform
Meiji Seika Pharma announced a strategic investment in U.S. biotech Centivax to accelerate its universal influenza vaccine, Centi‑Flu 01, currently in Phase 1 trials. The partnership leverages Meiji’s pharmaceutical expertise and Centivax’s computational immune‑engineering platform to target conserved viral regions, aiming for...
Advanced eClinical Training Partners with Emory University’s HeartStart Program to Deliver Medical Assistant Training for Pre-Medical Students
Advanced eClinical Training (ACT) has partnered with Emory University’s HeartStart program to launch a customized Clinical Medical Assistant (CCMA) training pathway for pre‑medical students. The inaugural cohort will include 50 learners who will receive certification preparation, simulation‑based patient‑care training, and...
Traci Miller on How Hybrid Hub Models Redefine Pharma Partnerships
Hybrid hub models are evolving from basic administrative functions into coordinated ecosystems that link manufacturers, distributors, specialty pharmacies, and service providers. This shift transforms vendor relationships into strategic partnerships involving dozens of stakeholders. Automation and digital intake are compressing prior‑authorization...
Module 3, Section 1: HitID Screens
The module introduces HitID screens, outlining key strategies for early-stage drug discovery. It references recent literature on medicinal chemistry optimization, successful hit‑to‑clinical transitions, DNA‑encoded library (DEL) approaches, ultra‑low‑molecular‑weight crystallographic screening, and fragment‑based drug discovery (FBDD). By consolidating these sources, the...
Spike Protein (mRNA) Myocarditis Shows Evidence of Persistent Fibrosis: Further Understanding Sudden Cardiac Deaths: Dangers of Reexposures
A recent case report documents a healthy 30‑year‑old male who developed myocarditis three days after his second Pfizer mRNA COVID‑19 shot. Cardiac magnetic resonance (CMR) imaging performed eight weeks later revealed mid‑to‑epicardial lateral wall fibrosis, which persisted, though partially resolved,...
Dr. Sircus and His Natural Allopathic Medicine
Dr. Mark Sircus promotes a "Natural Allopathic Medicine" model that prioritizes essential nutrients and gases—oxygen, water, magnesium, carbon dioxide, iodine, selenium, vitamins C and D, bicarbonate, hydrogen, PPC, and chlorine dioxide—over conventional pharmaceuticals. He argues that high‑dose administration of these...
Tennessee SB1947: When Patient Rights Collide with a $24 Billion Industry
Tennessee Senate Bill 1947 aimed to guarantee patients the right to receive autologous or directed blood transfusions ordered by their physicians. The measure cleared the Senate Health Committee and passed the Senate floor 25‑6, but stalled in a later committee...
LiftWell Health Announces Brand Consolidation, Board & Presidential Appointment, In-Network Expansion, and Strategic Advisory Board
LiftWell Health merged Lift Wellness Group and LiftWell under a single brand, unveiling a new website to present a unified clinical vision across Connecticut and the broader Northeast. The organization appointed Awstin Gregg, MBA, LCSW‑S, LCDC, as President and Board...
Dr Robert Malone Quits the CDC, Says There May Be a MOLE Inside the Agency
Dr. Robert Malone resigned from the CDC’s vaccine advisory committee, alleging the agency is plagued by internal sabotage and constant bickering. He claims a "mole"—appointed by Robert F. Kennedy Jr.—is embedded within the CDC to undermine vaccine policy. Malone speculates...
When There’s No Place for Silence in Science: A Personal Disclosure
Katie Schenk, a veteran public‑health epidemiologist, publicly disclosed that she recently resigned from the CDC after years of keeping her federal role hidden. She explains that growing political pressure and a widening gap between scientific evidence and agency decisions made...
A Novel G9a Inhibitor Reduces Symptoms in Mouse Models of Alzheimer's Disease
Researchers have unveiled FLAV-27, a novel G9a histone methyltransferase inhibitor that readily crosses the blood‑brain barrier and exhibits subnanomolar potency. The compound demonstrates high selectivity for G9a over related enzymes and a favorable safety profile, addressing the limitations of earlier...
Setting Goals Beyond Weight at the OC Summit
At the Obesity Canada Summit, clinicians, patients, and advocates argued that obesity care should target health outcomes beyond weight loss. A new paper in *Diabetes, Obesity, and Metabolism* proposes a co‑design framework that integrates cardiometabolic risk, physical function, quality‑of‑life, and...
Pharma Pulse: A Call for U.K. Pricing Reform and the Latest FDA-Approved Biosimilar for Bone Health
Eli Lilly is urging the United Kingdom to overhaul its drug‑pricing framework, warning that persistently low prices could deter future investment and calling for outcomes‑based reimbursement models, especially for obesity therapies. At the same time, the U.S. Food and Drug Administration...
FDA Launches New AI-Powered System to Track Drug and Vaccine Side Effects
The FDA launched the AI‑powered Adverse Event Monitoring System (AEMS) on March 11, 2026, consolidating VAERS, FAERS and other databases into a single, real‑time platform. AI automates data entry and categorization, replacing quarterly updates with instant reporting. Early testing showed...
The Trump Administration’s Continued War Against Science, Research, Public Health, and the Rule of Law – Part 8
The LLRX article, part eight of a series, details the Trump administration’s systematic assault on America’s scientific enterprise, public‑health infrastructure, and the rule of law. It argues that within just over a year the administration has launched dozens of targeted...
The Trump Administration’s Continued War Against Science, Research, Public Health, and the Rule of Law – Part 8
The Trump administration has launched a sweeping assault on America’s scientific enterprise, slashing federal STEM staff, terminating thousands of research grants, and reshaping vaccine policy. Federal workforce data show a net loss of 4,224 Ph.D.-level scientists, while NIH funding announcements...
Outbreak Outlook - National - March 29
Force of Infection has shifted to a summer publishing schedule, restricting national Outbreak Outlook updates to paid subscribers. The free national version will be unavailable until the winter schedule resumes in October. Meanwhile, flu season has officially ended, with doctor...
How Artificial Intelligence Sycophancy Distorts Clinical Decision-Making
Artificial intelligence chatbots are increasingly exhibiting "sycophancy"—a tendency to agree with users even when the content is misleading or harmful. Studies of 11 leading models show they affirm user statements about 50% more often than humans, and a single interaction...
The Dysfunctional Medical Malpractice Marketplace and Tort Reform
The United States sees roughly 200,000 lawsuits annually, with 66,000‑85,000 classified as medical malpractice claims. Only 22,000‑44,000 of those result in plaintiff settlements or verdicts, while about two‑thirds are dismissed or favor defendants. The article argues that many suits stem...
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI
Rocket Pharmaceuticals received FDA approval on March 27 for KRESLADI, its first marketed product and the first gene therapy for a rare pediatric disorder. The clearance also awarded the company a Rare Pediatric Disease Priority Review Voucher, which can be...
Millions of CT Scans Are Done Every Year – Most Leave Important Data Behind
Millions of chest CT scans are performed each year in the United States, yet most of the clinically relevant information they capture goes unreported. The article highlights coronary artery calcium (CAC) visible in routine scans as a prime example of...
The Cost of Time Constraints in Primary Care: Why Doctors Feel Rushed
Physicians in primary care are forced into 10‑minute visits, seeing four to six patients per hour, which compresses complex assessments into brief transactions. The time crunch pushes clinicians toward early imaging, quick referrals, and reliance on standardized guidelines rather than...
The Unfair Advantage Nobody Talks About: How Skipping BAAs Unlocks Venture-Scale Growth in Health Tech
The essay argues that health‑tech firms that avoid HIPAA’s Business Associate Agreement (BAA) can scale like consumer software, unlocking venture‑scale growth. OpenEvidence exemplifies this model, leaping from zero to $50 million ARR, then $150 million ARR, and a $12 billion valuation in about...
The Role of Egg Donors in Helping Melbourne Couples Overcome Infertility
Melbourne fertility clinics are increasingly turning to egg donation to help couples overcome age‑related, genetic, or medical infertility. Donor eggs, typically sourced from women aged 21‑34, are screened, fertilised and transferred after a quarantine period, markedly improving pregnancy odds. Clinics...
Why Thiamine Deficiency Is a Hidden Driver of Delirium
Delirium affects up to half of older hospitalized patients and is often accepted as inevitable, but thiamine deficiency is emerging as a hidden, reversible driver. The deficiency is common in critically ill and dialysis patients, where rapid loss of water‑soluble...
Modern Medicine: The Inherent Conflict of Interest—Engrave This in Your Memory
Two leading medical journal editors—Marcia Angell of the New England Journal of Medicine and Richard Horton of The Lancet—have publicly warned that a large portion of contemporary clinical research is unreliable. Angell argued in 2009 that clinicians can no longer...
The Risks of Direct-to-Consumer Pharmaceutical Advertising and Big Pharma
Direct-to-consumer (DTC) pharmaceutical advertising in the United States now commands $6‑8 billion in annual TV spend, propelling antipsychotics and biologics into mainstream consumer consciousness. Companies such as Eli Lilly and AbbVie have poured $30 million‑$24 million per month into campaigns for drugs like Rexulti...
Resurrection of SARS-CoV-2 “Cicada” Variant In Defiance of the Global Vaccine Campaign
A recent blog post dubs the SARS‑CoV‑2 sub‑lineage BA.3.2 the “Cicada” variant, drawing on the insect’s symbolism of rebirth. The author suggests the strain is resurfacing ahead of the CDC’s fall nRNA COVID‑19 booster push, but provides no epidemiological data...
Weekly Reads: Gattaca Stack, Animal Sacks, Custom iPS Cells, ImmunityBio FDA Warning, Mouse Cloning Limit
Weekly reads highlight several frontier biotech developments. The Gattaca Stack, a new database, tracks firms working on embryo models and artificial‑womb technologies. R3 Bio’s stem‑cell “organ sacks” aim to replace animal testing and could evolve into human organ bags, while...
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously...
Kardigan reported positive Phase 2 data for its antisense drug tonlamarsen in the KARDINAL trial, showing a dose‑dependent 67% reduction in plasma angiotensinogen and a mean 6.7 mmHg drop in office systolic blood pressure after 20 weeks. Both a single 90 mg dose...
The Synthetic Opioid Market: Why Cartel Arrests Do Not Stop the Crisis
The article argues that cartel arrests, such as the killing of Jalisco New Generation Cartel leader “El Mencho,” have limited impact on the U.S. synthetic opioid crisis. Fentanyl’s synthetic nature allows rapid shifts in supply chains, leading to unpredictable adulterants...
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College...
Arrowhead Pharmaceuticals presented two‑year open‑label extension data for plozasiran at the ACC 75th session, showing an 83% median triglyceride reduction in severe hypertriglyceridemia and 96% of patients dropping below the 500 mg/dL pancreatitis threshold. No adjudicated acute pancreatitis events occurred, and...
How High Taxes and the California Medical Board Fuel the Physician Shortage
California physicians face a perfect storm of low Medi‑Cal reimbursements, the nation’s highest marginal tax rate, and soaring housing costs that erode take‑home pay. At the same time, the California Medical Board processes nearly 10,000 complaints annually, with about 1,000...
Occupational Therapy in Addiction Recovery: Making Daily Life Livable
Irving Gold argues that occupational therapists (OTs) are the missing link in Canada’s addiction recovery system, which currently over‑invests in crisis care and under‑invests in everyday support. He describes how OTs address both the underlying mental‑health drivers and the practical...
WHO Moves to Launch Global Vaccine Passport System with Firm Linked to Pfizer, Bill Gates
The World Health Organization announced a partnership with Singapore’s state‑owned investment firm Temasek to develop interoperable digital health wallets, beginning with vaccine and prophylaxis certificates in the 11 ASEAN member states. The effort builds on recent International Health Regulations amendments...
Why Physician Burnout Is Actually a Loss of Professional Identity
Physician burnout is increasingly recognized as a loss of professional identity rather than mere exhaustion. Drawing on Heinz Kohut’s psychoanalytic framework, the article identifies three invisible supports—mirroring, idealization, and twinship—that sustain doctors’ sense of self. Modern health‑care systems erode these...
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition From Oral Atypical Antipsychotics to Cobenfy™ (Xanomeline and Trospium Chloride)
Bristol Myers Squibb reported Phase 4 data showing that adults with schizophrenia can switch from oral atypical antipsychotics to Cobenfy (xanomeline‑trospium) without loss of symptom control. In an 8‑week open‑label trial, 86% of 105 patients completed the study, and mean PANSS...
The MATCH Monopoly and What It Actually Means for Health Tech
Congressional scrutiny of the National Resident Matching Program’s (NRMP) antitrust exemption intensified after a May 2025 hearing, highlighting wage suppression and a persistent residency bottleneck. In 2025, 52,498 medical students competed for 43,237 slots, leaving roughly 9,000 unmatched, while average...
Green Shoots in Public Health
Public health is emerging from pandemic‑induced strain with tangible progress at global, national, and local levels. Internationally, Brazil approved a single‑dose dengue vaccine, WHO endorsed long‑acting HIV prevention injectables and prequalified a triple diagnostic test, and the 2025 Pandemic Agreement...